Founded in 2002 by surgical oncologist Prof. Dr. Hartmut Juhl, Hamburg-based Indivumed GmbH is a biotech company developing precision-oncology therapeutics from patient-derived cancer data. Its clinically grounded R&D combines more than 20 years of standardized tumor-sample collection with proprietary multi-omics analysis and patient-derived tumor models to identify and validate drug targets. A global clinical network spanning North America, Europe, and Asia gives the company a broad, patient-native view of cancer biology.
Hamburg District Court HRB 81965
Registration
Precision Medicine GroupFounded in 2012, Precision Medicine Group is a global life-sciences services company built to change how new drugs reach patients. Its 3,500 experts support pharmaceutical and biotechnology clients across clinical development and commercialization, using data and technology to address complex healthcare challenges.BETHESDA, MD
Predictive OncologyPittsburgh-based Predictive Oncology uses machine learning, human tumor data and laboratory models to support oncology drug discovery and clinical treatment decisions. Its proprietary platform draws on a privately held biobank of more than 150,000 tumor samples, while its CLIA-certified Helomics laboratory provides tumor drug-response and genomic testing alongside research support for biopharmaceutical developers.PITTSBURGH, PA
ANPAC Bio-Medical Science Co., LtdFounded in 2010 by scientists spanning medicine, physics, biology, biochemistry and nanotechnology, ANPAC Bio-Medical Science develops multi-cancer detection and early cancer-risk screening technologies. The company’s patented Cancer Differentiation Analysis approach has been used in more than 300,000 multi-cancer test samples, supporting screening for cancer risks in the general population.AMBLER, PA
NovocureNovocure grew from Professor Yoram Palti’s basement laboratory in Haifa, where he began exploring electric fields as a way to target cancer cells in 2000. Today, the international oncology company develops and commercializes Tumor Treating Fields therapy for patients facing some of the most aggressive solid tumors, while continuing research into wider applications.WAYNE, PA